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Abstract
Summary We performed an association study of five
candidate genes within chromosome 3p14-25 in 1,080
Chinese female subjects. Polymorphisms in FLNB/CRTAP
are associated with bone mineral density (BMD) in
Chinese.
Introduction Chromosomal region 3p14-25 has shown
strong evidence of linkage to BMD in genome-wide
linkage scans. The variants responsible for this linkage
signal, nonetheless, remain obscure.
Methods Thirty SNPs in five positional and functional
candidate genes within 3p14-25 (PPARG, CRTAP, TDGF1,
PTHR1, and FLNB) and rs7646054 in the ARHGEF3 gene
were genotyped in a case-control cohort of 1,080 Chinese
females. Allelic and haplotypic association were tested
using logistic regression analysis implemented in PLINK
software. Potential transcription factor binding sites were
predicted with MatInspector.
Results Multiple SNPs and haplotypes in FLNB were
significantly associated with BMDs, with the strongest
association between lumbar spine BMD and rs9828717
(p=0.005). SNP rs7623768 and the haplotype G-C of
rs4076086-rs7623768 in CRTAP were associated with
femoral neck BMD (p=0.009 and p=0.003, respectively).
PTHR1 showed haplotypic associations with lumbar spine
and femoral neck BMD (p=0.02 and p=0.044, respectively).
Nevertheless, the association between rs7646054 in
ARHGEF3 and BMD observed in Caucasians was not
replicated in our samples. Comparative genomics analysis
indicated that rs9828717 is located within a highly conserved
region. The minor T allele at rs9828717 may lead to loss of
binding site for nuclear factor of activated T cells which
binds and triggers the transcriptional program of osteoblasts.
Conclusions Our data suggest that variants in FLNB and
CRTAP at 3p are involved in BMD regulation in southern
Chinese.
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Introduction
Osteoporosis is a complex disease characterized by low
bone mass and microarchitectural deterioration of bone
tissue, leading to enhanced bone fragility and a consequent
increase in fracture risk [1]. Assessment of bone mineral
density (BMD) is a common approach to evaluate the risk
of osteoporosis. BMD is under strong genetic control with
heritability ranging from 0.63 to 0.75 at the femoral neck,
0.61 to 0.83 at the lumbar spine, and 0.66 to 0.79 at total
hip [2–4]. Recently published genome-wide association
studies have revealed a few well-known candidate genes,
such as low-density lipoprotein receptor-related protein 5,
receptor activator of nuclear factor kappa B ligand (RANKL),
osteoprotegerin, estrogen receptor 1, and sclerostin as the
causal genes that contribute to BMD variation [5–7]. Since
these genes are thought to account for only a small
proportion of the total variation in spine and hip BMD,
further identification of additional variants remains vital to
understand the pathogenesis of osteoporosis.
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Chromosomal region 3p14-25 is a susceptible quantitative
trait locus (QTL) for BMD regulation that has been identified
by four independent linkage studies [8–11] and genome scan
meta-analyses [12, 13]. The meta-analysis of published
linkage scores in 12,685 individuals from 3,097 families
suggested that the summed rank of 3p22.2-p14.1 (bin 3.3) is
significantly higher than expected (p=0.012) [12]. Our
recent meta-analysis of genome-wide linkage data, which
included 11,842 subjects from 3,045 families, showed that
3p25.3-p22.1 (bin 3.2) had a statistically significant high
average rank for lumbar spine BMD in both the whole-
sample and female-specific analysis [13].
Mullin et al. [14] recently genotyped 17 SNPs in Rho
guanine nucleotide exchange factor 3 (ARHGEF3) and
observed the strongest association for rs7646054, which
was associated with BMD Z-score at spine (p=0.006) and
femoral neck (p=0.0007) in postmenopausal Caucasian
women. The Rho guanine nucleotide exchange factor 3
specifically activates two members of the RhoGTPase
family: RHOA which has been implicated in osteoblast
differentiation and RHOB which has a role in cartilage
biology [14]. It is unclear whether rs7646054 exerts the
same effect in Chinese women who have a different genetic
background and lower osteoporosis prevalence compared
with Caucasian women [15].
To identify the causal genes contributing to BMD
regulation in 3p14-25, a gene-wide and tag SNP-based
association study was conducted in 1,080 case-control
subjects using both single marker and haplotype approaches
on five candidate genes: peroxisome proliferator-activated
receptor gamma (PPARG), cartilage-associated protein
(CRTAP), teratocarcinoma-derived growth factor 1
(TDGF1), parathyroid hormone receptor type 1 (PTHR1),
and filamin B, beta (FLNB). The bone-related traits and
phenotypes in knockout mice of these five genes are
summarized in Table 1. A SNP rs7646054 in novel
ARHGEF3 gene, which was recently reported to be
associated with BMD regulation in Caucasians [14], was
also examined in our population.
Materials and methods
Subjects
This study included 1,080 southern Chinese female subjects
selected from an expanding database of the Hong Kong
Osteoporosis Study. Participants were ambulatory subjects
recruited at road shows and health talks on osteoporosis
since 1998. Women with a history of diseases known to
affect bone mass including vitamin D deficiency, hyper-
calcaemia, primary and secondary hyperparathyroidism,
hyper- and hypothyroidism, metabolic and congenital bone
diseases, and use of medications that would affect bone
metabolism were excluded. A detailed description of
subject ascertainment, inclusion, and exclusion criteria has
been described previously [4]. BMD was measured by dual
energy X-ray absorptiometry (Hologic QDR 4500 plus,
Waltham, MA, USA). The in vivo precision of the machine
for lumbar spine, femoral neck, and total hip region was
1.2%, 1.5%, and 1.5%, respectively. Subjects with extreme
BMD Z-scores at either lumbar spine L1–4 or femoral neck
were included in the current study. Subjects with BMD
Z-score≤−1.28 (lowest tenth percentile of the population)
were defined as cases, while those with BMD Z-score≥+1
(highest 15th percentile of the population) were defined as
controls. All participants gave informed consent, and the study
was approved by the Ethics Committee of the University of
Hong Kong and conducted according to the Declaration of
Helsinki.
There were 457 cases and 254 controls for lumbar spine,
399 cases and 283 controls for femoral neck, and 356 cases
and 260 controls for total hip. The Student's t test was
applied to compare the characteristics and phenotypes of
the cases and controls. Age, height, and weight are potential
confounding factors influencing BMD variation. According
to our previous heritability estimates for BMD, the
proportion of variation explained by age, age2, height, and
weight was around 0.3 in women [4]. Factors with
significant difference in the cases and controls were
employed as covariates in the subsequent analysis.
SNP selection and genotyping
Twenty-seven tag SNPs (tSNPs) from five candidate genes
(PPARG, CRTAP, TDGF1, PTHR1, and FLNB) in the
chromosomal region 3p14-25 were selected for genotyping
based on the genotype data obtained from the Han Chinese
panel of the phase II HapMap data [39]. The criterion for
tagging was set at r2>0.8 and minor allele frequency
(MAF)>0.2. The 27 tag SNPs captured 82.4% of common
variants in five genes. SNPs rs709157, rs2177153, and
rs1131356 showed significant association with BMD in
previous studies and are thus, examined in this study. A
total of 30 SNPs were genotyped using high-throughput
massArray technology. In the genotyping process, 5% of
samples were duplicated for quality check, and the
reproducibility rate exceeded 99.8%.
Mullin et al. recently reported strong associations
between rs7646054 in ARHGEF3 and BMD Z-scores at
the spine and femoral neck in postmenopausal women [14].
We, thus, also genotyped rs7646054 using the TaqMan
Genotyping Assay C__29978110_10 (Applied Biosystems,
CA, USA) in our case-control samples. Each reaction
contained template DNA and a final concentration of 1x
TaqMan PCR Master Mix, unlabeled forward and reverse
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primers, VIC, and 6FAM dye-minor groove binder labeled
probe for detection of the two alleles. The polymerase chain
reaction program was set at 50°C incubation for 2 min
followed by 10 min at 92°C. A two-step reaction was
repeated with 40 cycles, with denaturation at 92°C for 15 s
and annealing and extension at 50°C for 1 min. Subsequent
endpoint reading was performed on the PRISM 7000
Sequence Detection System (Applied Biosystems, CA,
USA). The reproducibility and the call rate of the TaqMan
assay were 100% and 98.7%, respectively.
Statistical analysis
PLINK, an open source tool set designed for analysis of large
data sets in a computationally efficient manner [40], was
utilized in quality control filtering, single- and multiple-
marker association tests. SNPs missing greater than10%,
MAF of less than 1%, or violating the Hardy–Weinberg
equilibrium (HWE) (p<0.001) were excluded from further
analysis. Logistic regression for the additive model, with
adjustment for covariates, was applied to test the single-
marker genotypic association with BMD at different skeletal
sites. The Fisher's exact test was employed to execute the
basic allelic association test. The variable-size sliding
window approach was adopted in haplotype analysis as it
includes the SNPs that may fall outside predefined linkage
disequilibrium (LD) block and thus, enables the full
information on genetic variability to be utilized in haplotype
analysis [41, 42]. Another advantage of the variable-size
sliding window approach is its greater detection power
compared with other association-mapping strategies that
employ haplotype block or single-SNP locus [41]. With
adjustment of covariates, global omnibus test was conducted
on a set of SNPs: in H haplotypes with a frequency more
than1%, an H-1 degree of freedom test was performed to
compare the alternate model (each haplotype having a
unique effect) with the null (no haplotypes having any
different effect). When the omnibus test was deemed
significant, haplotype-specific test was performed. A condi-
tional haplotype test that controlled for a particular haplotype
among a set of haplotypes was also conducted to determine
if that particular haplotype alone leads to the significant
omnibus association result. Haploview 4.1 [43] was adopted
to generate the haplotype block structure for the genotyped
markers that passed the quality control requirements. LD is
not calculated if markers are greater than 500 kb apart.
Statistical power was estimated by the “Case-Control for
threshold-selected quantitative traits” module of the web-
based Genetic Power Calculator (http://pngu.mgh.harvard.
edu/~purcell/gpc/qcc.html) [44].
Table 1 The gene–disease/trait association and bone-related phenotypes of the gene-deficient mice of the five candidate genes
Gene Gene–disease/trait association in humans Bone-related phenotypes of target-gene-deficient mice
FLNB Boomerang dysplasia [16] Smaller body size, reduced body weight, “hourglass”
body shape, restricted upper body movement, and
aberrant mineralization in the neural arches leading
to fusion of individual vertebrae [22]
Larson syndrome [17, 18]
Spondylocarpotarsal synostosis [18, 19]
Atelosteogenesis I and III [18, 20] Kyphotic and scoliotic malformations of the vertebral
column, reduced body weight, shorter bones, reduced
BMD in the middiaphyseal area of tibiae, reduced cortical
thickness, reduction in hyaline cartilage in the ribs,
metacarpal bones, phalanges, and tarsal bones [23]
BMD [21]
PPARG Serum osteoprotegerin level [24, 25] PPARG+/− mice exhibit high bone mass compared with
wild-type mice. The difference in bone volume between
the mice of two genotypes becomes more prominent
at 52 weeks [27]
Total body BMD [26]
PTHR1 Femoral neck BMD [28–31] No abnormal bone-related phenotypes were reported
in PTHR1-deficient miceEiken syndrome [32]
Blomstrand chondrodysplasia [32, 33]
CRTAP Osteogenesis imperfecta [34–37] Shortening of long bone segments (particularly the
proximal segment of the limb), decreased bone
volume/tissue volume ratio, decreased trabecular
thickness, decreased trabecular number, increased
trabecular separation, reduced bone formation rate
due to a reduction in the mineral apposition rate, and
decreased mineralization lag time [35]
TDGF1 Ranked first in the prediction of
osteoporosis candidate genes
within the 3p14-25 [38]
No abnormal bone-related phenotypes were reported
in TDGF1-deficient mice
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Bioinformatics analysis
A comparative genomics approach was adopted to
determine potential functional elements in the candidate
region associated with BMD variation. The chromosomal
position of the region was submitted to the VISTA
Genome browser. Pre-computed whole-genome align-
ment among large vertebrates, which had a high
sensitivity in covering more than 90% of known exons,
was available on the browser with timely update upon
the release of new genome assemblies [45].
The sequence encompassing the significantly associated
SNP was scanned against the weight matrices for vertebrates
that were publicly available on MatInspector [46]. The
optimized matrix threshold of a weight matrix was defined
as the threshold that allowed a maximum of three matches in
10 kb of non-regulatory test sequences. The matrix similarity
was calculated on-the-run by scanning the imported sequence
against the relative frequency of each nucleotide at a particular
position in the matrix. Only potential binding sites with: (1)
matrix similarity exceeding the optimized threshold; and (2)
matrix similarity greater than 0.85 were considered good
matches.
Results
Subject characteristics
The characteristics of the subjects are outlined in Table 2.
Student's t test was used to compare the mean age, height,
weight, and BMD in the case- and control-group, without
assuming equal variances. The covariates that showed
significant differences between cases and controls were
potential confounding factors for BMD variation. These were
adjusted in the subsequent analysis as indicated in Table 2.
Quality control
The genomic position, MAF, HWE test statistic, and call
rate for each tSNPs that satisfied quality control criteria are
listed in Table 3. Two tSNPs (rs4684846 and rs4135280)
had call rates less than 90%. One SNP (rs1805192) was
monomorphic in our study population. These three SNPs,
all located within PPARG, were excluded from further
analysis. A SNP in CRTAP (rs4678478) violated the HWE
with a p<0.001 in both the case- and control-group and was
also discarded from association analysis.
Single-marker association
The association of each SNP with BMDs at the lumbar
spine, femoral neck, and total hip was evaluated using the
additive and allelic model. SNPs with p value≤0.05 in the
single-marker association test are shown in Table 4. Multiple
SNPs (rs9828717, rs1718454, and rs1718456) in FLNB
showed significant genotypic association with lumbar spine
BMD (p=0.03–0.005). For femoral neck BMD, significant
genotypic association was detected for rs7623768 in CRTAP
(p=0.009) and rs1718456 in FLNB (p=0.027). Significant
association with total hip BMD was only observed for
multiple SNPs in FLNB: rs9828717, rs1718454, and
rs9822918 (p=0.016–0.048).
Haplotype analysis
SNPs with MAF of less than 0.1 were removed from the
haplotype analysis to reduce the type I error rate. Table 5
lists the combinations of SNPs most significantly associated
with BMD in each gene resulting in p<0.05 in the
covariate-adjusted omnibus test. Only haplotypes with
frequency of greater than 0.05 are shown in the table.
The global omnibus test revealed that a region
rs724448–rs2242116 within the PTHR1 gene, which was
in strong LD (r2=0.96), was significantly associated with
lumbar spine and femoral neck BMD after adjustment of
height and weight (p=0.02 and p=0.044, respectively).
FLNB showed regional associations with BMDs at all three
measured skeletal sites. The region rs9828717–rs1718456–
rs1718481–rs1718454 was significantly associated with lum-
bar spine BMD (p=0.003). However, none of the common
haplotypes are associated with lumbar spine BMD. The
region rs1718456–rs1718481–rs1718454 was significantly
associated with femoral neck BMD (p=0.03). The T–A–C
haplotype was associated with lower BMD status (p=0.013,
odds ratio (OR)=1.52) while the C–A–C haplotype was
associated with higher BMD status (p=0.0145, OR=0.41).
The global omnibus test was no longer significant after
controlling for either of the haplotypes, indicating their
potential role in regulation of femoral neck BMD. The region
rs1718454–rs9822918 was significantly associated with total
hip BMD (p=0.027). The C–T and T–G haplotype were
correspondingly associated with the increased (p=0.006, OR=
1.69) and reduced risk of low BMD (p=0.025, OR=0.66).
The global omnibus test demonstrated that the region
rs4076086–rs7623768 inCRTAP was significantly associated
with femoral neck (p=0.028) and total hip BMD (p=0.015).
According to the haplotype-specific and conditional haplo-
type test, G–C was potentially the haplotype that conferred a
protective effect on femoral neck (p=0.003, OR=0.43) and
total hip (p=0.007, OR=0.44) BMD.
rs7646054 in ARHGEF3 and BMD
Mullin et al. [14] recently reported a significant association
between rs7646054 and BMD Z-score in postmenopausal
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women: subjects homozygous for the G allele had lower
BMD than subjects heterozygous or homozygous for the A
allele. The same model (AA+AG vs GG) was, therefore,
adopted in the analysis of this SNP using logistic regression
implemented in SPSS. No association was observed
between rs7646054 and BMD Z-score at the lumbar spine,
femoral neck, or total hip in the whole study population,
nor in the 533 postmenopausal case-controls (results not
shown).
Bioinformatics analysis
Since four of the five SNPs genotyped within intron 1 of
FLNB showed significant associations with BMD in the
single-marker test, the chromosomal position of intron 1
(Chr3:57,969,624-58,037,812) was submitted to VISTA
genome browser to determine the presence of any potential
conserved elements. RankVISTA for multiple alignment
shows that intron 1 of FLNB in humans is a conserved
noncoding sequence among five other species, including
rhesus, dog, horse, mouse, and rat (Fig. 1). It is worth noting
that rs9828717 is located within a highly conserved region
with an alignment p value of 2.4×10−16. Prediction of
potential transcription factor binding sites with MatInspector
revealed that the minor T allele at rs9828717 may lead to the
loss of binding site for nuclear factor of activated T cells
(NFAT). The similarity score for the major C allele with
NFAT matrix was 0.96.
Discussion
In the present study, we tested associations between
common variants in five candidate genes in 3p14-25
(FLNB, PPARG, TDGF1, CRTAP, and PTHR1) and BMD
in 1,080 southern Chinese women. Among these candidate
genes, FLNB showed the strongest and most consistent
association with BMD in both single-marker and haplotype
analysis. At the SNP level, rs9828717, rs1718456,
rs1718454, and rs9822918 were significantly associated
with lumbar spine, femoral neck, or total hip BMD
(p=0.005–0.029). At the haplotype level, the strongest
association was observed with total hip BMD for the
haplotype C–T of rs1718454–rs9822918 (p=0.006,
OR=1.69). Additionally, SNP rs7623768 and the haplotype
G–C of rs4076086–rs7623768 in CRTAP is associated with
Table 2 Characteristics and BMD measurements of the 1,080 subjects and the constituent 533 postmenopausal women
Whole study population Postmenopausal women
Cases Controls p value (t test) Cases Controls p value (t test)
Skeletal site: lumbar spine
Number 457 254 – 314 107 –
Age (year) 51.71±13.78 49.56±14.35 0.05 59.92±5.90 63.55±8.16 <0.01*
Height (m) 1.53±0.06 1.576±0.06 <0.01* 1.52±0.057 1.55±0.05 <0.01*
Weight (kg) 49.98±7.22 60.34±9.76 <0.01* 51.03±7.43 62.45±9.79 <0.01*
BMD (g/cm2) 0.71±0.09 1.12±0.10 <0.01 0.66±0.07 1.06±0.10 <0.01
BMD Z-score −1.73±0.40 1.53±0.63 <0.01 −1.8±0.43 1.68±0.71 <0.01
Skeletal site: femoral neck
Number 399 283 – 186 98 –
Age (year) 45.89±15.27 45.56±14.32 0.77 60.60±6.09 61.05±8.26 0.63
Height (m) 1.54±0.06 1.46±1.087 <0.01* 1.51±0.06 1.54±0.06 <0.01*
Weight (kg) 48.44±6.40 61.11±12.31 <0.01* 49.64±7.07 63.41±9.17 <0.01*
BMD (g/cm2) 0.56±0.07 0.90±0.10 <0.01 0.51±0.05 0.83±0.06 <0.01
BMD Z-score −1.68±0.34 1.58±0.53 <0.01 −1.7±0.36 1.48±0.38 <0.01
Skeletal site: total hip
Number 356 260 – 194 86 –
Age (year) 48.44±14.70 45.51±13.76 0.01* 60.52±6.02 60.97±7.59 0.63
Height (m) 1.54±0.06 1.54±0.66 0.99 1.52±0.06 1.55±0.057 <0.01*
Weight (kg) 48.62±6.37 62.42±10.88 <0.01* 49.57±6.78 64.38±9.00 <0.01*
BMD (g/cm2) 0.63±0.07 0.99±0.07 <0.01 0.59±0.06 0.93±0.06 <0.01
BMD Z-score −1.83±0.44 1.67±0.54 <0.01 −1.89±0.49 1.60±0.45 <0.01
*p<0.05, the parameters with * are adjusted as covariates in subsequent analysis
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femoral neck BMD (p=0.009 and p=0.003, respectively).
PTHR1 showed haplotypic associations with lumbar spine
and femoral neck BMD (p=0.02 and p=0.044, respectively).
Mutations in FLNB have been observed in a number of
human skeletal disorders, including boomerang dysplasia
[16], Larson syndrome [17, 18], spondylocarpotarsal
synostosis [18, 19], and atelosteogenesis I and III [18,
20]. Together with the intense and uniform FLNB expression
detected throughout the growth plate in normal mouse
embryos in resting, proliferating, and prehypertrophic and
hypertrophic chondrocytes, it is thought that FLNB plays a
central role in skeletogenesis and joint formation [18].
Interestingly, a number of mutations that lead to the broad
phenotypic spectrum are located within the actin-binding
domain of FLNB. A functional actin cytoskeleton may be
important for many normal morphogenetic processes,
including skeletogenesis [16].
The phenotypes of FLNB-deficient mice also revealed
the importance of the gene in skeletogenesis. FLNB−/− mice
have vertebral fusions and abnormalities and decreased
hyaline cartilage in the vertebral, carpal, and tarsal bones
(Table 1) similar to the human clinical malformations
seen in vertebral segmentation, joint formation, and
skeletogenesis in the syndromes of spondylocarpotarsal
syndrome [22, 23], atelosteogenesis I and III [23], Larsen
syndrome [23], and boomerang dysplasia [23]. Scoliotic
and kyphotic abnormalities of the vertebral column in
FLNB−/− mice resemble those observed in human boomerang
dysplasia [23].
In addition to these monogenic bone diseases, FLNB is
also associated with human BMD measured at various sites.
SNPs rs9822918 and rs2177153 were associated with age-
corrected BMD at both the femoral neck (p=0.02–0.0002)
and total hip (p=0.02–0.0006) in 771 women from the
Table 3 The genomic position, minor allele frequency (MAF), Hardy–Weinberg equilibrium (HWE) test statistic, linkage disequilibrium (LD)
plot, and call rate for each of the SNPs
Gene LD (D´) plot SNP ID Genomic
position (bp)
Genic
position 
Alleles
(major/minor)
MAF HWE
p 
Call
rate
PPARG rs17036188 12315925 Intron 1 C/T 0.388 0.112 0.997 
3p25 rs2028760 12347882 Intron 1 A/G 0.382 0.326 1.000 
rs10510418 12363563 Intron 1 A/C 0.162 0.344 0.987 
rs2938392 12409608 Intron 4 C/T 0.448 0.070 0.925 
rs1875796 12418657 Intron 4 C/T 0.447 0.154 0.994 
rs4135275 12418844 Intron 4 A/G 0.456 0.521 1.000 
rs1822825 12424963 Intron 5 C/T 0.448 0.160 0.998 
rs709157 12437024 Intron 6 A/G 0.011 0.1126 0.999 
rs3856806 12450557 Exon 7 T/C 0.275 1.000 0.998 
CRTAP rs11129545 33134270 Intron 1 A/G 0.456 0.797 0.999 
3P22.3 rs4076086 33136902 Exon 2 A/G 0.463 0.600 0.998 
rs7623768 33157056 Intron 6 A/C 0.270 1.000 1.000 
rs12635415 33162086 3´ A/G 0.264 0.678 0.979 
TDGF1 rs11130097 46595618 Exon 2 C/T 0.390 1.000 0.995 
3p21.31 rs2280413 46596797 Intron 5 C/T 0.129 0.317 0.997 
rs1049667 46598694 3´ A/C 0.168 0.049 0.983 
PTHR1 rs6442037 46904550 Intron 3 A/G 0.306 1.000 0.996 
3p22-p21.1 rs724448 46910738 Intron 4 G/T 0.422 0.005 0.999 
rs2242116 46916120 Intron 8 C/T 0.425 0.002 0.994 
FLNB rs9828717 57974026 Intron 1 C/T 0.499 0.481 0.997 
3p14.3 rs1718456 57987388 Intron 1 C/T 0.448 0.438 0.999 
rs1718481 58000943 Intron 1 A/G 0.495 0.160 1.000 
rs1718454 58025988 Intron 1 C/T 0.362 0.213 1.000 
rs9822918 58032724 Intron 1 G/T 0.325 0.827 0.994 
rs2177153 58067386 Intron 11 A/G 0.022 0.376 0.999 
rs1131356 58084202 Exon 21 A/G 0.077 1.000 1.000 
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Table 5 Result of haplotype association tests
Gene Markers Omnibus test
(adjusted p value)
Haplotype-specific test Omnibus test controlling for
haplotype (adjusted p value)
Haplotype Frequency Adjusted p value Odds Ratio
Phenotype: lumbar spine BMDa
PTHR1 rs724448 0.02* GC 0.40 0.01* 0.59 NAc
rs2242116 TT 0.59 0.02* 1.60 NAc
FLNB rs9828717 0.003* TCGT 0.29 0.04* 0.72 0.009*
CCGC 0.05 0.203 1.59 0.003*rs1718456
TCGC 0.14 0.479 1.16 0.002*rs1718481
CTAC 0.39 0.083 1.30 0.005*rs1718454
TCAC 0.05 0.144 0.59 0.004*
Phenotype: femoral neck BMDa
CRTAP rs4076086 0.028* GC 0.21 0.003* 0.43 0.959
rs7623768 AC 0.06 0.886 0.93 0.011*
GA 0.26 0.273 1.34 0.019*
AA 0.47 0.094 1.49 0.042*
PTHR1 rs724448 0.044* GC 0.40 0.031* 0.62 NAc
rs2242116 TT 0.59 0.044* 1.55 NAc
FLNB rs1718456 0.031* CGT 0.29 0.121 0.77 0.042*
rs1718481 CGC 0.19 0.571 1.12 0.018*
rs1718454 TAC 0.40 0.013* 1.52 0.194
CAC 0.05 0.015* 0.41 0.177
Phenotype: total hip BMDb
CRTAP rs4076086 0.015* GC 0.21 0.007* 0.44 0.217
rs7623768 AC 0.06 0.264 1.93 0.010*
GA 0.27 0.127 1.57 0.017*
AA 0.47 0.622 1.14 0.006*
FLNB rs1718454 0.027* CT 0.30 0.006* 1.69 0.478
rs9822918 TG 0.33 0.025* 0.66 0.127
CG 0.34 0.781 0.95 0.011*
NA not applicable
a Adjusted for height and weight as covariates
b Adjusted for age and weight as covariates
c Only haplotypes GC and TT were observed for rs724448 and rs2242116. Both alleles of rs724448 were never observed on the same haplotypic
background. In this case, the null model is identical to the alternate model, and hence, the control effect cannot be tested
*p<0.05
Table 4 SNPs significantly associated with BMD in additive model
SNP Gene Lumbar spine BMD (adjusted
with height and weight)
Femoral neck BMD (adjusted
with height and weight)
Total hip BMD (adjusted
with age and weight)
p value Odds ratio p value Odds ratio p value Odds ratio
rs7623768 CRTAP 0.33 0.87 (0.65–1.15) 0.009* 0.66 (0.48–0.90) 0.099 0.75 (0.53–1.06)
rs9828717 FLNB 0.005* 1.51 (1.13–2.00) 0.09 1.32 (0.96–1.82) 0.048* 1.43 (1.00–2.04)
rs1718456 FLNB 0.029* 1.37 (1.03–1.83) 0.027* 1.44 (1.04–1.99) 0.14 1.30 (0.92–1.85)
rs1718454 FLNB 0.029* 0.73 (0.55–0.97) 0.08 0.76 (0.56–1.03) 0.019* 0.66 (0.47–0.93)
rs9822918 FLNB 0.27 1.19 (0.88–1.61) 0.105 1.31 (0.95–1.81) 0.017* 1.55 (1.08–2.23)
*p<0.05
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GENOS sib-pairs study [21]. Such association was replicated
in a population-based cohort of 1,192 unrelated Caucasian
women from the CAIFOS (CAlcium Intake Fracture
Outcome Study)/CARES (Caring for Adults Recovering
from the Effects of Stroke) study [21]. Both rs9822918 and
rs2177153 were included in our present study. In our cohort,
rs9822918 was also significantly associated with total hip
BMD (p=0.017, OR=1.55). No association was nevertheless
observed for rs2177153 (p>0.05). The large discrepancy
between the MAF of rs2177153 in Caucasian (MAF=0.292
from HapMap) and southern Chinese women (MAF=0.02
from the present study) may explain the association
difference.
Kiel et al. [47] used the Affymetrix 100K SNP GeneChip
marker set in the Framingham Heart Study to examine genetic
associations with BMD. Two SNPs inFLNB were included in
the 100K marker set. According to the results available at
http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?
study_id=phs000007.v3.p2, rs1658397 was significantly
associated with lumbar spine BMD using the additive
generalized estimating equation model (p=0.0005) while
rs6445945 demonstrated only a modest association (p=0.03)
in all the 1,141 phenotyped individuals. Both rs1658397 and
rs6445945 are located within the BMD-associated
rs9828717–rs1718456–rs1718481–rs1718454–rs9822918
locus. Nevertheless, HapMap phase II data revealed a large
discrepancy in the MAF of these two markers between
different ethnic groups. The frequency of the minor allele C
of rs1658397 is 0.325 and 0.044 in Europeans and Han
Chinese, respectively. With a MAF of 0.4 in the European
population, rs6445945 is monomorphic in the Han Chinese.
Thus, other variants within the locus may affect BMD
regulation in the southern Chinese population. In our study,
association was more significant at haplotype level than
single-marker level, presumably implying that the real causal
variant is located within this locus but was not tagged.
Another possibility is that overall variation in this locus may
influence BMD regulation. We have recently demonstrated
that multiple genes at 1p36 contribute to osteoporosis
susceptibility in Chinese [48]. Resequencing and genotyping
with higher marker density in the FLNB gene may provide
more evidence of a regional association with BMD.
The strongest association was observed for rs9828717
with lumbar spine BMD. Comparative genomics analyses
indicated that the rs9828717 is located within a conserved
noncoding sequence. Prediction of potential transcription
factor binding sites shows that the minor T allele at
rs9828717 may abolish the binding site of NFAT that the
major C allele possesses. NFAT is a family of transcription
factors with activity inhibited by calcineurin inhibitors.
Bone loss has been observed in both humans [49] and rats
[50] treated with calcineurin inhibitors. Such bone loss is
attributable to the suppressive effects of calcineurin
inhibitors on osteoblast differentiation and osteoblastic
bone formation [51]. This has outweighed its inhibition of
osteoclastogenesis by suppressing NFAT induction by
RANKL [52]. In addition, NFATc2 knockout mice suffered
from a reduction of trabecular bone volume caused by the
downregulation of markers for osteoblastic bone formation
[51]. The regulatory role of NFAT in osteoblastogenesis is
in line with our association result that the minor T allele
increases the risk of low BMD, as NFAT fails to bind and
trigger the transcriptional program of osteoblasts.
CRTAP is expressed in both osteoblasts and osteoclasts.
CRTAP shares homology with a family of putative prolyl
3-hydroxylases and can form a complex with cyclophilin B
and prolyl 3-hydroxylase 1 which is crucial for bone
development and collagen helix formation [53]. Loss of
CRTAP in mice causes osteochondrodysplasia which is
characterized by severe osteoporosis due to deficient bone
formation [35]. Loss of CRTAP in humans is associated
with recessive osteogenesis imperfecta [35]. In the current
study, rs7623768 in CRTAP is significantly associated with
femoral neck BMD (p=0.009), and the haplotype G–C of
rs4076086–rs7623768 is consistently associated with
femoral neck BMD (p=0.003) and total hip BMD
(p=0.007). We recently demonstrated that variants of the
sclerostin gene that cause sclerosteosis and van Buchem
disease are also associatedwith osteoporosis [54]. Association
of CRTAP polymorphisms with femoral neck BMD further
supports previous observations that genes associated with
monogenic bone diseases also contribute to BMD variation
and osteoporosis risk in the general population.
PTHR1 is a member of the superfamily of G-protein-
coupled receptors. The gain-of-function mutations in the
PTHR1 gene cause Jansen's metaphyseal chondrodysplasia
that is characterized by growth plate abnormalities and
increased bone resorption, while loss-of-function mutations
in PTHR1 cause Blomstrand chondrodysplasia which is
characterized by advanced endochondral bone maturation
and increased BMD. In the current study, PTHR1 showed
haplotypic association with lumbar spine and femoral neck
BMD (p=0.02 and p=0.044, respectively), although no
association was observed between BMD and individual
SNP in PTHR1. It is worth noting that two previous studies
also reported the association of BMD with haplotypes but
not single SNPs in this region of PTHR1 [29, 31]. It is
likely that untyped common variant or multiple rare
variants are responsible for the observed association.
Because SNPs in this region of PTHR1 are in strong LD,
it is difficult to clearly define the primary associated
variant(s) by population genetics approaches. Functional
assessment of the variants via computational methods,
laboratory assays, or model systems will be required to
determine variant(s) responsible and the mechanism of the
observed association.
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The strength of our study is that the selected sampling
strategy can substantially increase power over random
sampling for detection of allelic association [55]. Assuming
a marker is in complete LD (D′=1) with a QTL or the
causal allele accounting for 1% of BMD variation and the
MAFs of the marker and QTL are both 0.1, more than 98%
power can be achieved to detect the additive genetic effects
of the marker at a significance level of α=0.05 in the whole
study population. Making the same assumptions with use of
the same parameters, the power was 87%, 77%, and 73%
for lumbar spine, femoral neck, and total hip BMD,
respectively, in the postmenopausal women subgroup.
Based on the power calculation, our study should have
sufficient power to detect any association between a marker
and BMD. Nonetheless, this study failed to replicate the
association between rs7646054 in ARFGEH3 and BMD in
postmenopausal women recently observed by Mullin et al.
[14]. The limitation of this study was that some susceptibility
genes/variants may have been missed in this well-replicated
region, because a candidate gene approach was used. Recent
genome-wide association studies demonstrated that many
associations implicate non-protein-coding regions [5–7].
Another limitation of this study was no correction for
multiple testing. Although smaller p values generally provide
greater support for a true association, it is the consistency
and strength of the association across one or more replication
studies, rather than the strength of the p value in a single
study, that is critical to exclude false-positive association.
Thus, we mainly evaluated the significance of our associa-
tion in relation to previous replication. Since our design and
choice of SNPs was based on evidence drawn from previous
linkage and functional studies, our success to replicate the
Fig. 1 VISTA browser plot of the comparative analysis for intron 1 in FLNB (Chr3:57,969,624-58,037,812 on the human March 2006 genome).
The position of rs9828717 was indicated by the red arrow
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association of some of the SNPs provides evidence that these
associations are likely to be valid.
In conclusion, our results suggest that FLNB and CRTAP
are promising susceptibility genes for BMD regulation
within 3p14-25 in the southern Chinese women. Further
replication and functional studies are required to elucidate
their role in bone remodeling.
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